Brief: Aeterna Zentaris Qtrly Loss Per Common Share $0.30
May 7 (Reuters) - Aeterna Zentaris Inc AEZS.TO :
* AETERNA ZENTARIS REPORTS FIRST QUARTER 2019 FINANCIAL AND
OPERATING RESULTS
* QTRLY LOSS PER COMMON SHARE $0.30
* Q1 LOSS PER SHARE $0.30
* AS OF MARCH 31, 2019, CO HAD $11.4 MILLION OF UNRESTRICTED
CASH
AND CASH EQUIVALENTS
Source text for Eikon: ID:nGNX9tZv5T
Further company coverage: AEZS.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on COSCIENS Biopharma
See all newsBrief: COSCIENS Acquires Nualtis Corp
Refile: Canada's COSCIENS Biopharma Q2 net loss narrows on higher sales
Canada's COSCIENS Biopharma Q1 net income turns positive on discontinued German operations
Brief: Cosciens Biopharma Inc Not Aware Of Material Undisclosed Information Amid Recent Trading Activity
Brief: Cosciens Provides Strategic Update